David J. Schlanger - 17 Oct 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role: Executive Chairman, Director
Signature: /s/ Mark Livingston, Attorney-in-Fact
Issuer symbol: PGNY
Transactions as of: 17 Oct 2022
Net transactions value: -$1,307,146
Form type: 4
Filing time: 19 Oct 2022, 16:20:09 UTC
Previous filing: 17 Oct 2022
Next filing: 24 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGNY	Common Stock	Options Exercise	$1,183	+1,300	+1.6%	$0.9100^*	83,848	17 Oct 2022	Direct
transaction	PGNY	Common Stock	Sale	$51,142	-1,300	-1.6%	$39.34	82,548	17 Oct 2022	Direct	F1, F2
transaction	PGNY	Common Stock	Options Exercise	$29,538	+32,459	+39%	$0.9100^*	115,007	18 Oct 2022	Direct
transaction	PGNY	Common Stock	Sale	$1,251,834	-31,596	-27%	$39.62	83,411	18 Oct 2022	Direct	F1, F3
transaction	PGNY	Common Stock	Sale	$34,891	-863	-1%	$40.43	82,548	18 Oct 2022	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGNY	Option (Right to Buy)	Options Exercise	$0	-1,300	-0.09%	$0.000000	1,419,328	17 Oct 2022	Common Stock	1,300	$0.9100	Direct	F5
transaction	PGNY	Option (Right to Buy)	Options Exercise	$0	-32,459	-2.3%	$0.000000	1,386,869	18 Oct 2022	Common Stock	32,459	$0.9100	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.33 to $39.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.37 to $40.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.40 to $40.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5	These options are fully vested and exercisable.